Patent Application
20180094284
This application claims the benefit of Korean Patent Application No. 10-2016-0127547, filed on Oct. 4, 2016, in the Korean Intellectual Property Office, the disclosure of which is incorporated herein in its entirety by reference.
Incorporated by reference in its entirety herein is a computer-readable nucleotide/amino acid sequence listing submitted concurrently herewith and identified as follows: One 36,664 Byte ASCII (Text) file named “728237_ST25.TXT,” created on Oct. 4, 2017.
The present disclosure relates to a recombinant protein, a gene encoding the recombinant protein, a recombinant microorganism, and a method of degrading a macromolecular substance.
Macromolecular materials, otherwise known as plastics, have gradually replaced conventional materials, such as glass, metal, paper, wood, and stone in various applications ranging from industrial materials to disposable consumables. The disposal of used plastic waste depends on incineration or landfills. However, due to leakage of hormones into the environment and incomplete combustion of waste from which toxic dioxin is detected, used plastic waste causes serious problems in terms of environmental pollution of soil, rivers, and the atmosphere.
In order to solve these problems, there is great pressure to put biodegradable or biointegrable plastics into practical use and obligate their usage. Thus, in countries including the United States, Japan, Germany, and Italy, biodegradable plastics have actively been put into practical use. For example, there is a requirement to use biodegradable macromolecular materials in various plastic products. Currently, the most widely used synthetic plastics in the industry are polyethylene (PE), polyurethane (PUR), nylon, and polyvinylalcohol (PVA). To promote decomposition of such synthetic plastics, methods including photolysis, pyrolysis, and biodegradation are used. Photolysis induces oxidation of a macromolecular material by using ultraviolet rays of sunlight. Pyrolysis changes properties of a macromolecular material through application of heat thereto. Biodegradation is degradation of macromolecular materials by aerobic or anaerobic microorganisms.
Among the above-mentioned decomposition methods, biodegradation by microorganisms is the most efficient. However, there is a need to develop new microorganisms and methods to efficiently degrade macromolecular materials. This invention provides such microorganisms and methods.
Provided is a recombinant protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7, and a gene including a nucleotide sequence encoding same.
Also provided is a recombinant microorganism that expresses or includes a recombinant protein at an increased level relative to a parent strain, the protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7.
Further provided is a method of degrading a macromolecular substance, the method including contacting the macromolecular substance with a recombinant microorganism, a lysate thereof, or a fraction of the lysate thereof, the recombinant microorganism that expresses or includes a recombinant protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7.
These and/or other aspects will become apparent and more readily appreciated from the following description of the embodiments, taken in conjunction with the accompanying drawings in which:
Reference will now be made in detail to embodiments, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to like elements throughout. In this regard, the present embodiments may have different forms and should not be construed as being limited to the descriptions set forth herein. Accordingly, the embodiments are merely described below, by referring to the figures, to explain aspects. Expressions such as “at least one of,” when preceding a list of elements, modify the entire list of elements and do not modify the individual elements of the list.
The term “gene” as used herein refers to a nucleic acid that expresses a specific protein or polypeptide, and may include a sequence associated with a coding region and a regulatory sequence associated with regions other than the coding region, such as a 5′-non coding sequence and 3′-non coding sequence. A regulatory region of the gene may include a promoter, an enhancer, an operator, a ribosome-binding site, a polyA-binding site, and a terminator region.
The term “sequence identity” as used herein in connection with a polynucleotide or polypeptide refers to a degree of sameness of bases or amino acid residues of two sequences after aligning the two sequences to a maximum match in a particular comparison region. The sequence identity is a value obtained by comparing two sequences that are optimally aligned in a specific comparison region. A part of sequences in a comparison region may be added or deleted in comparison with a reference sequence. The sequence identity (%) may be, for example, calculated by comparing sequences that are optimally aligned throughout a comparison region, by determining the number of positions at which the same amino acids or nucleotide nucleotides appear in both sequences to obtain the number of matched positions between the two sequences, dividing the number of the matched positions by the total number of positions in a comparison range, i.e., dividing the number of the matched positions by a range size, and multiplying the result by 100 to obtain sequence identity as a percentage. The sequence identity (%) may be determined using known sequence comparison programs, and examples of such programs include BLASTN or BLASTP (NCBI), CLC Main Workbench (CLC bio), and MegAlign™ (DNASTAR Inc).
Sequence identity of several levels may be used in identifying a polypeptide or polynucleotide of different species having the same or similar functions or activities. For example, a polypeptide or polynucleotide of one species may have at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or at least 100% sequence identity to a polypeptide or polynucleotide of another species.
The term “increase in activity”, “increased activity”, or “increased level” as used herein refers to a detectable increase in activity of a cell, polypeptide, protein, or enzyme relative to the activity of a cell, polypeptide, protein, or enzyme of the same type that does not have a given genetic modification (for example, a parent cell or a native or “wild-type” cell, polypeptide, protein, or enzyme). The term “cell activity” as used herein refers to activity of a specific polypeptide, protein, or enzyme of a cell. For example, the activity of the modified or engineered cell, polypeptide, protein, or enzyme may be increased by about 5%, about 10%, about 15%, about 20%, about 30%, about 50%, about 60%, about 70%, or about 100% relative to the activity of a cell, polypeptide, protein, or enzyme of the same type that does not have a given modification or has not been engineered, such as a wild-type cell, polypeptide, protein, or enzyme. Cells having increased activity of a polypeptide, protein, or enzyme may be confirmed by using any method known in the art. Cells having increased activity may have undergone genetic engineering for increasing activity of at least one enzyme or polypeptide thereof, as compared with cells that have not undergone genetic engineering.
One aspect provides a recombinant protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7.
The recombinant protein may be a recombinant protein including an amino acid sequence having at least 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO: 1; a recombinant protein including an amino acid sequence having at least 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO: 2; a recombinant protein including an amino acid sequence having at least 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO: 3; a recombinant protein including an amino acid sequence having at least 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO: 4; a recombinant protein including an amino acid sequence having at least 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO: 5; a recombinant protein including an amino acid sequence having at least 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO: 6; or a recombinant protein including an amino acid sequence having at least 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NO: 7. In addition, a recombinant protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7 may include a protein having a same function as a protein having an amino acid sequence of one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7, and a modification such as substitution, deletion, or insertion of at least one amino acid, or a combination thereof. Also provided is a combination of such proteins.
The recombinant protein may have activity of an oxygenase. The oxygenase refers to an enzyme that catalyzes oxidation (i.e., a reaction in which an oxygen atom binds to a substrate) and may be an enzyme that adds a carbonyl group to a macromolecular substance, adds a carbon-oxygen bond to a macromolecular substance, or oxidizes a carbon-oxygen bond or carbon-carbon bond of a macromolecular substance. The recombinant protein may act on a carbon-hydrogen bond or carbon-carbon bond of a macromolecular substance. For example, the recombinant protein may catalyze conversion of a carbon-hydrogen bond or carbon-carbon bond of a macromolecular substance to a carbon-oxygen bond, i.e., a carbonyl group, of a macromolecular substance. In some embodiments, the recombinant protein may be an enzyme classified as EC.1.13, or EC.1.14, such as an enzyme classified as EC. 1.14.14.9, EC. 1.13.12.16, EC. 1.14.14.5, or EC. 1.14.99.48.
The recombinant protein may be from a microorganism belonging to the genus Bacillus. The microorganism belonging to the genus Bacillus may be the Bacillus YP1.
Another aspect provides a gene including a nucleotide sequence encoding any of the recombinant proteins described herein. In one embodiment, the gene may include a nucleotide sequence encoding a recombinant protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7.
In one embodiment, the polynucleotide including the nucleotide sequence may be codon-optimized for a particular recombinant microorganism. The expression “codon-optimized” as used herein indicates that a gene configured to encode the same amino acid is produced, but at least one codon thereof is substituted with a codon that is favorable for expression in the particular microorganism.
The gene may include at least one nucleotide sequence selected from the group consisting of nucleotide sequences of SEQ ID NOs: 8 to 14. A nucleotide sequence encoding a recombinant protein that includes an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 1 may include a nucleotide sequence of SEQ ID NO: 8. A nucleotide sequence encoding a recombinant protein that includes an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 2 may include a nucleotide sequence of SEQ ID NO: 9. A nucleotide sequence encoding a recombinant protein that includes an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 3 may include a nucleotide sequence of SEQ ID NO: 10. A nucleotide sequence encoding a recombinant protein that includes an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 4 may include a nucleotide sequence of SEQ ID NO: 11. A nucleotide sequence encoding a recombinant protein that includes an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 5 may include a nucleotide sequence of SEQ ID NO: 12. A nucleotide sequence encoding a recombinant protein that includes an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 6 may include a nucleotide sequence of SEQ ID NO: 13. A nucleotide sequence encoding a recombinant protein that includes an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 7 may include a nucleotide sequence of SEQ ID NO: 14.
Another aspect provides an expression vector including any one of the polynucleotides or genes described herein. Any vector that may be used to introduce a polynucleotide or gene into a microorganism may be used herein. The gene or polynucleotide optionally includes a restriction enzyme site that cooperates with a vector to be inserted, and thus may be effectively cloned into an expression vector. To express the recombinant protein, such an expression vector may optionally include a promoter sequence, a translation initiation sequence, and a translation termination sequence. The vector may be a plasmid or a viral vector.
Another aspect provides a recombinant microorganism that expresses or includes a protein as described herein, or a combination of such proteins (e.g., a protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, and/or 7 at an increased level relative to a parent strain).
The recombinant microorganism may have increased activity of an oxygenase relative to a parent strain. The recombinant microorganism may have a genetic modification to produce a recombinant protein that degrades a bond of a macromolecular substance upon oxidation. The genetic modification may include an exogenous or foreign (heterologous) gene or polynucleotide encoding a protein with oxygenase activity as described herein.
The recombinant microorganism may include a gene that encodes a recombinant protein at an increased copy number relative to a parent strain, the protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7.
The recombinant microorganism may include at least one gene encoding a protein or a combination thereof, the protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7. For example, the recombinant microorganism may include at least two, three, four, five, ten, or fifty genes encoding a protein having at least 95% sequence identity to one of SEQ ID NOs: SEQ ID NOs: 1, 2, 3, 4, 5, 6, and/or 7. When the recombinant microorganism includes a plurality of genes, each of the plurality of genes may be identical to or different from each other, or may encode the same or different proteins having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7. The at least one gene may be an exogenous gene that is integrated into the genome of the microorganism or may remain independent from the genome of the microorganism.
The gene may include a nucleotide sequence selected from the group consisting of nucleotide sequences of SEQ ID NOs: 8 to 14. The amino acid sequences of SEQ ID NOs: 1 to 7, the nucleotide sequences of SEQ ID NOs: 8 to 14, and the recombinant protein are the same as described above.
Regarding the recombinant microorganism, the gene may be introduced into the microorganism by any method known in the art, for example, transformation, electroporation, or the like.
The recombinant microorganism may be bacteria, yeast, or fungi. The bacteria may be gram-positive or gram-negative. The gram-negative bacteria may belong to the genus Escherichia, the genus Xanthomonas, genus Xanthobacter, the genus Salmonellar, or the genus Pseudomonas. The microorganism belonging to the genus Escherichia may be E. coli. The gram-positive bacteria may belong to the genus Corynebacterium or the genus Bacillus. The bacteria may belong to the genus Saccharomyces. The protein may be produced in large quantities using the recombinant microorganism.
Another aspect provides a composition for degrading a macromolecular substance including any recombinant microorganism described herein, a lysate thereof, or a fraction of the lysate thereof, the microorganism expressing or including a recombinant protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7.
The microorganism may be a recombinant microorganism expressing or including a protein or a combination thereof at an increased level relative to a parent strain, the protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7.
The recombinant microorganism may include a gene encoding a protein or a combination thereof at an increased copy number relative to a parent strain, the protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7. The gene may include at least one nucleotide sequence selected from the group consisting of nucleotide sequences of SEQ ID NOs: 8 to 14.
The composition may degrade a macromolecular substance. The composition may catalyze degradation of a macromolecular substance. The composition may catalyze oxidation or conversion of a carbon-hydrogen or carbon-carbon bond to a carbon-oxygen bond, i.e., a carbonyl group, of a macromolecular substance. Degradation may refer to division of a macromolecular substance into units similar to that of a repeat unit of the macromolecular substance, or reduction of force or intensity applied to a macromolecular substance required for breakage of a macromolecular substance. Here, the force or intensity applied required for the breakage may be measured by tensile strength, which may be measured by methods known in the art. For example, the tensile strength may be measured by using a texture analyzer, a universal testing machine, or an injection machine. In addition, degradation may refer to a decrease in a molecular weight, a mass, a weight, crystallinity, a thickness of a crystal layer, a melting temperature, an average size of crystals, or an increase in an amount of small crystals, each of which may be measured by methods known in the art.
The term “macromolecule” as used herein refers to a polymer or a copolymer.
The macromolecular substance may include a polyalkylene, a polyacrylic acid, and/or a polystyrene.
The macromolecular substance may have a weight average molecular weight (MW) in a range of about 10,000 Da to about 300,000 Da, about 50,000 Da to about 250,000 Da, about 100,000 Da to about 200,000 Da, or about 130,000 Da to about 180,000 Da. The MW may be measured by conventional method of measuring the molecular weight of a polymer. A macromolecular substance including a polyalkylene may include an alkylene repeat unit of 1 to 10 carbon atoms. For example, the number of carbon atoms of the alkylene repeat unit in the macromolecular substance may be in a range of 2 to 8, 2 to 6, or 2 to 4. The repeat unit may include ethylene, propylene, or butylene. The macromolecular substance may include, for example, polyethylene, polypropylene, or polybutylene. Polyethylene may be a macromolecular substance that is very stable and synthesized by polymerization of ethylene monomers. In some embodiments, the recombinant protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7, and/or recombinant microorganism expressing or including same may biodegrade the macromolecular substance without the need for additional steps such as UV degradation, pyrolysis, photolysis, or chemical degradation using strong acids.
Another aspect provides a method of degrading a macromolecular substance, the method including contacting a macromolecular substance with a recombinant microorganism, a lysate thereof, or a fraction of the lysate thereof, wherein the microorganism expresses or includes a protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7. All aspects of the microorganisms, macromolecular substance, and other aspects of the method are as previously described.
The microorganism may be a recombinant microorganism including a protein or a combination thereof at an increased level relative to a parent strain, the protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, and/or 7. The recombinant microorganism may include a gene encoding a protein including an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 1, 2, 3, 4, 5, 6, or 7. The gene may include at least one nucleotide sequence selected from the group consisting of nucleotide sequences of SEQ ID NOs: 8 to 14.
The lysate refers to a state in which the microorganism is broken up so that contents thereof are exposed to the outside of a cell. The lysate may be obtained by breaking up a cell by using an enzyme, heat, or pressure. The lysate may include the recombinant microorganism extract, recombinant protein extract, or crude extracts thereof.
The fraction of the lysate may be obtained by separation from a material dissolved in an aqueous or oily solvent.
The contact may be in liquid or solid form. The contact may be performed by, for example, contacting the macromolecular substance with a microorganism cultured in a medium, a culture of the microorganism, a lysate of the microorganism and/or the culture, or a fraction of the lysate.
The contact may be liquid-liquid and/or liquid-solid contact which is contact of the macromolecular substance with the microorganism, a culture of the microorganism, a lysate of the microorganism and/or the culture, or a fraction of the lysate. The liquid-liquid and/or liquid-solid contact may include mixed contact. The contact may be performed in a sealed container or an open container. The term “sealed” as used herein refers to a state substantially or completely fastened or closed securely (e.g., air-sealed, liquid-sealed, liquid-tight, air-tight, or combination thereof depending on the nature of the sample). The contact may be performed in an anaerobic or aerobic condition. The contact may be performed when the growth stage of the microorganism is in an exponential phase or a stationary phase.
The contact may include culturing or incubating the microorganism while contacting the microorganism with a sample containing the macromolecular substance. The contact may be performed under conditions in which the microorganism can survive in a sealed container. The conditions in which the microorganism can survive may include a condition in which the microorganism proliferates or a condition that maintains the microorganism in a resting state. The culturing may be performed under conditions suitable for proliferating the microorganism. The culturing may refer to culturing under conditions for culturing the microorganism. The conditions for culturing the microorganism include, for example, a carbon source, nitrogen source, or oxygen source condition used for the strain. The carbon source may include a monosaccharide, a disaccharide, or a polysaccharide. The carbon source may include glucose, fructose, sucrose, mannitol, mannose, maltose, lactose, xylose, glycerol, sorbitol, cellobiose, ethanol, or galactose. The nitrogen source available for the microorganism may include an organic nitrogen compound or an inorganic nitrogen compound. The nitrogen source may include, for example, an amino acid, an amide, an amine, a nitrate, or an ammonium salt. The medium used for culturing the microorganism may include any conventional medium suitable for the growth of a host cell, and an example thereof is a minimal or complex medium containing appropriate supplements. Such a suitable medium may be available from a commercial vendor or may be prepared according to methods known in the art. The medium used for the culturing may be a medium that can satisfy the requirements of the microorganism. The medium may include a medium selected from the group consisting of a carbon source, a nitrogen source, a salt, a trace element, and a combination thereof. The culturing may be performed under aerobic conditions. A temperature at which the culturing is performed may be in a range of about 15° C. to about 35° C. A pH of the culture medium may be in a range of about 4 to about 8. The culturing may be static culturing or stirring culturing.
The contact may be performed in a batch manner or in a continuous manner. The contact may include, for example, contacting the contacted macromolecular substance obtained from the degradation with a recombinant microorganism having increased oxygenase activity relative to a parent strain, a lysate of the recombinant microorganism, or a fraction of the lysate, wherein the recombinant microorganism may include a recombinant microorganism including an exogenous gene that encodes a protein having oxygenase activity.
The contact with the recombinant microorganism, a lysate thereof, or a fraction of the lysate may be performed once or two or more times, for example, 2, 3, 5, 10, or more times. The contact may be continued or repeated until a desired repeat unit of the macromolecular substance is obtained. The contact may be performed for about 1 to about 15 days, about 2 to about 14 days, about 3 to about 12 days, about 4 to about 10 days, about 5 to about 9 days, or about 6 to about 8 days.
In the method, for one contact of the macromolecular substance, the macromolecular substance may be applied as a degradation subject in an amount ranging from about 1 mg to about 500 mg, about 2 mg to about 250 mg, about 5 mg to about 100 mg, about 10 mg to about 50 mg, about 20 mg to about 40 mg, or about 25 mg to about 35 mg.
In the method, the contact may be performed under conditions of pH in a range of about 4 to about 10, about 5 to about 9, about 6 to about 8, or about 7 to about 8.
The microorganism, a lysate of the microorganism, or a fraction of the lysate may include a recombinant protein in an amount ranging from about 10 mg to about 200 mg, about 15 mg to about 150 mg, about 16 mg to about 120 mg, or about 17 mg to about 110 mg.
The amino acid sequences of SEQ ID NOs: 1 to 7, the nucleotide sequences of SEQ ID NOs: 8 to 14, the recombinant protein, the degradation, and the macromolecular substance are the same as described above.
In various embodiments, the recombinant microorganism may be used to remove a macromolecular substance. The term “remove” as used herein refers to reduction of the amount of the macromolecular substance. The reduction may include partial or complete removal of the macromolecular substance.
The following further illustrate the invention but, of course, should not be construed as in any way limiting its scope.
In Example 1, recombinant E. coli strains expressing polypeptides of SEQ ID NOs: 1 to 7, respectively, were prepared, and an effect of degradation of polyethylene was confirmed using the recombinant E. coli.
(1) Preparation of Recombinant E. coli that Expresses Polypeptides of SEQ ID NOs: 1 to 7
All of genes derived from Bacillus sp. YP1 were prepared by synthesizing DNA to be optimized for codons of E. coli (Cosmogenetech). PCR was performed by using DNA synthesized herein as a template, and a primer set of nucleotide sequences of SEQ ID NOs: 15 and 16, a primer set of nucleotide sequences of SEQ ID NOs: 17 and 18, a primer set of nucleotide sequences of SEQ ID NOs: 19 and 20, a primer set of nucleotide sequences of SEQ ID NOs: 21 and 22, a primer set of nucleotide sequences of SEQ ID NOs: 23 and 24, a primer set of nucleotide sequences of SEQ ID NOs: 25 and 26, or a primer set of nucleotide sequences of SEQ ID NOs: 27 and 28, thereby amplifying and obtaining genes of SEQ ID NOs: 8 to 14.
The amplified gene of SEQ ID NO: 8 (T2), the amplified gene of SEQ ID NO: 9 (T4), the amplified gene of SEQ ID NO: 10 (T5), the amplified gene of SEQ ID NO: 11 (T6), the amplified gene of SEQ ID NO: 12 (T8), the amplified gene of SEQ ID NO: 13 (T9), and the amplified gene of SEQ ID NO: 14 (T10) were each ligated into pET28a vectors (Novagen, Cat. No. 69864-3), which had been digested with NcoI and XhoI restriction enzymes, using an InFusion Cloning Kit (Clontech Laboratories, Inc.) to prepare pET28a-PE vectors for expressing T2, T4, T5, T6, T8, T9, and T10 genes, respectively. The expressed genes were each then named pT4, pT5, pT6, pT8, pT9, and pT10.
Next, each of the prepared pT2, pT4, pT5, pT6, pT8, pT9, and pT10 vectors was introduced to an E. coli BL21 strain by a heat shock method (Sambrook, J & Russell, D. W., New York: Cold Spring Harbor Laboratory Press, 2001), and then the strains were cultured on an LB plate containing kanamycin (50 μg/mL). A strain showing kanamycin resistance was screened and selected from the cultured strains. Finally, the selected strain was then designated as a recombinant E. coli BL21/pT2, a recombinant E. coli BL21/pT4, a recombinant E. coli BL21/pT5, a recombinant E. coli BL21/pT6, a recombinant E. coli BL21/pT8, a recombinant E. coli BL21/pT9, and a recombinant E. coli BL21/pT10.
(2) Evaluation of Effect of a Recombinant E. coli Expressing Polypeptides of SEQ ID NOs: 1 to 7 on Degradation of a Macromolecular Substance
Effects of the E. coli BL21/pT2, BL21/pT4, BL21/pT5, BL21/pT6, BL21/pT8, BL21/pT9, and BL21/pT10 strains into which each of SEQ ID NOs: 8 to 14 was introduced prepared in Example 1(1) were examined in relation to degradation of a macromolecular substance.
Each of the E. coli BL21/pT2, BL21/pT4, BL21/pT5, BL21/pT6, BL21/pT8, BL21/pT9, and BL21/pT10 strains were cultured in a TB medium at a temperature of 30° C. while being stirred at 230 rpm. At OD600 of about 0.5, 0.2 mM of IPTG was added thereto, followed by culturing at a temperature of 20° C. while being stirred at 230 rpm overnight.
Cells were harvested from the culture by centrifugation. The BugBuster protein extraction reagent (Novagen) was used to disrupt the cell walls of E. coli, thereby obtaining crude extracts of E. coli. Amino acid sequences of proteins in the crude extracts are shown in Table 2. The total protein concentration in the crude extracts was quantified by a Bradford method. The total protein concentration in the crude extracts and the amount of protein used in degradation of polyethylene are shown in Table 3
(3) Measurement of Changes in Tensile Strength of a Macromolecular Substance
3 pieces of a polyethylene film having a weight average molecular weight of about 155,000, determined by Gel permeation chromatography (GPC), width×height of 1 cm×5 cm, and a mass of about 30 mg; and 10 mL of phosphate buffer saline (PBS) having a pH of 7.4 and containing 62.8 mg of crude extractions of T2 protein obtained from Example 1(2) were added to a 15 mL tube. The contents of the tube were reacted while being stirred at a temperature of 30° C. at 120 rpm for 7 days. Such a process was repeated in triplicate. As a control group, a crude extract obtained by introducing an empty pET28a vector to an E. coli BL21 strain by a heat shock method and culturing the recombinant microorganism was used. For each of T4, T5, T8, T9, and T10 protein, the same procedure was used except that an amount of protein shown in Table 3 was used. After the reaction, the polyethylene film pieces were washed with a 2% sodium dodecyl sulfate (SDS) solution for 4 hours, cleaned with deionized water, and dried at room temperature overnight.
The dried polyethylene film pieces were subjected to a texture analyzer (TA.XT plus, Stable Micro Systems) so that these samples were each pulled at 5 mm/min to calculate tensile strength, which is stress at the time of fracture. Table 4 shows changes in tensile strength of the polyethylene after reacting the polyethylene with a recombinant protein of T2, T4, T5, T8, T9, T10, and the control group.
As shown in Table 4, each of the crude extracts containing a recombinant protein of T2, T4, T5, T8, T9, or T10 shows significantly reduced tensile strength of polyethylene relative to that of the control group.
(4) Infrared Spectroscopy Change Measurement
Whether a C—H bond or C—C bond of polyethylene was converted into a C═O bond was confirmed by using a Fourier transform infrared spectrometer (FTIR) (Varian 670 IR, Agilent, Calif., USA). Spectroscopic analysis was carried out using a Miracle™ accessory manufactured by Pike Company (PA, USA) with an Attenuated Total Reflection Mode (ATR). For the total reflection of light, germanium crystals having an index of refraction of 4 were used. A mercury cadmium telluride (MCT, HgCdTe) detector including liquid nitrogen was used to measure light absorption properties of polyethylene at room temperature. At a measurement range of about 4,000 to about 650 cm−1, scanning was performed 64 times to obtain an absorption spectrum of an organic substance (polyethylene) against infrared rays.
Table 5 shows a peak ratio confirming that crude extracts containing T2, T4, T5, T6, T8, and T9, respectively, increase C═O bonds of the polyethylene compared to control. crude extracts containing T2, T4, T5, T6, T8, and T9, respectively, increased the C═O/C—H ratio by about 2.0 to about 2.7 fold.
All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
The use of the terms “a” and “an” and “the” and “at least one” and similar referents in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The use of the term “at least one” followed by a list of one or more items (for example, “at least one of A and B”) is to be construed to mean one item selected from the listed items (A or B) or any combination of two or more of the listed items (A and B), unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
Preferred embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
| Number | Date | Country | Kind |
|---|---|---|---|
| 10-2016-0127547 | Oct 2016 | KR | national |
